维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Hekele"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis显示文摘	Dall P Hekele A Ikenberg H		0，，02：	1
2	Surface proteun expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium显示文摘	Dall P Heider KH Hekele A	1994	Cancer Res1994，54，13：	1
3	The endocytic pathway mediates cell entry of dsRNA to induce RNAi si- lencing显示文摘	Saleh M C van Rij R P Hekele A	2006	Nat Cell Biol2006，8，8：	1
4	A regulatory element in the CD95 (AP0-1/Fas)ligand promoter is essential responsiveness to TCR-mediated activation 显示文摘	Li-Weber M Laur O Hekele A	1998	Ettr J Immunol1998，28，8：	1
5	Role of PARP on: NOS pathway during endotox in -induced acute lung injury 显示文摘	Kiefmann R Hekel K	2004	Intensive Care Med2004，30，7：	1
6	Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis显示文摘	Schenk P Schoniger Hekele M Fuhrmann V	2003	Gastroenterology2003，125，4：	1
7	Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy 显示文摘	Offner S Hekele A Teichmann U	2005	Cancer Immunol Irmnunother2005，54，5：	1
8	Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy显示文摘	Peter Ferenci Thomas–Matthias Scherzer Heidrun Kerschner Karoline Rutter Sandra Beinhardt Harald Hofer Maximilian Sch?niger–Hekele Heidemarie Holzmann Petra Steindl–Munda	2008	Gastroenterology2008，，5：	1
9	Hepatocel- lular carcinoma in central europe: prognostic features and survival 显示文摘	Schniger Hekele M Mailer C Kutilek M	2001	Gut2001，48，1：	1
10	Epithelial tight junction proteins aspotential antibody targets for pancarcinoma therapy显示文摘	Offner S Hekele A Teichmann U e t al	2005	Cancer Immunol Immunother2005，54，5：	1
11	Hepatocellular carcinoma in Austria:aetiological and clinical characteristics ar presentation In Process Citation ]显示文摘	Schoniger Hekele M Muller C Kutilek M Oesterreicher CFerenci P Gangl A		0，，：	1
12	et al A regulatory elment in the CD95 (APO-1/Fas)ligand promoter is essential for responsiveness to TCR-mediated activation显示文摘	LAUR O HEKELE A	1998	Eur J Immunol1998，28，8：	1
13	The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis显示文摘	Schoniger- Hekele M Muller C	2006	Dig Dis Sci2006，51，2：	1
14	Mdm2 gene Amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations显示文摘	Günther T Schneider-Stock R Hekel C	2000	Mod Pathol2000，13，6：	1
15	A regulatory clement in the CD95(APO-1/Fas) ligand promoter is essential responsiveness to FCR,mediated activation显示文摘	Li-weber M Laur O Hekele A	1998	Ear J Lmmunol1998，28，8：	1
16	Hepatocellular carcinoma in central Europe:prognostic features and survival 显示文摘	Schoniger - Hekele M Muller C Kutilek M	2001	Gut2001，48，1：	1
17	Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy 显示文摘	Offner S Hekele A Teichmann U	2005	Cancer Immunol Immunother2005，54，5：	1
18	Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes - a model/or immunogene therapy of cervixal cancer显示文摘	Dall P Hekele A Beckmann MW	1997	Gynecol Oncol1997，66，2：	1
19	The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing显示文摘	Saleh M C van Rij R P Hekele A	2006	Nat Cell Biol2006，8，：	1
20	Mutations at positions 186 and 194 in the HA gene of the,2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs显示文摘	Suphaphiphat P Franti M Hekele A	2010	Virology Journal2010，7，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示